Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Immunogen Inc (IMGN)

Immunogen Inc (IMGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Is AbbVie Stock a Buy Now?

The company is grappling with losing Humira's patent protection in 2023.

IMGN : 31.23 (unch)
CERE : 40.31 (-1.80%)
ABBV : 170.28 (+0.22%)
AbbVie's Recent ImmunoGen Acquisition Looks Brilliant: Here's Why

The acquisition fills an immediate need with some extras to boot.

ABBV : 170.28 (+0.22%)
IMGN : 31.23 (unch)
AbbVie Just Followed Pfizer's Big Move. Here's What It Means For Investors

It's making a major acquisition to beef up a key area of its pipeline.

PFE : 28.92 (+0.91%)
ABBV : 170.28 (+0.22%)
IMGN : 31.23 (unch)
AbbVie Just Announced 2 Big Acquisitions: Is This Dividend King a No-Brainer Buy Right Now?

The big drugmaker went on a holiday shopping spree.

AGN.AX : 0.900 (-3.23%)
ABBV : 170.28 (+0.22%)
IMGN : 31.23 (unch)
CERE : 40.31 (-1.80%)
AbbVie's on an Acquisition Binge. Could Your Favorite Biotech Stock Be Next?

Here's what's attracting lucrative buyout offers from big pharmaceutical companies these days.

ABBV : 170.28 (+0.22%)
CERE : 40.31 (-1.80%)
IMGN : 31.23 (unch)
Is AbbVie Stock a Buy Now?

AbbVie's business could soon become more diversified.

AGN.AX : 0.900 (-3.23%)
ABBV : 170.28 (+0.22%)
IMGN : 31.23 (unch)
Why Abbvie Stock Popped Today

The company announces a major deal worth over $10 billion.

ABBV : 170.28 (+0.22%)
IMGN : 31.23 (unch)
Drugmaker AbbVie to spend over $10B on ImmunoGen to juice its cancer-fighting treatment portfolio

AbbVie is spending more than $10 billion to add a potential blockbuster cancer treatment as cheaper versions of the drugmaker’s all-time best seller, Humira, cut into sales

$SPX : 5,615.35 (+0.55%)
$DOWI : 40,000.90 (+0.62%)
$IUXX : 20,331.49 (+0.59%)
IMGN : 31.23 (unch)
ABBV : 170.28 (+0.22%)
ImmunoGen: Q3 Earnings Snapshot

ImmunoGen: Q3 Earnings Snapshot

IMGN : 31.23 (unch)
Pioneering the Path to Cure Cancer: 2023's Biotech Innovations

VANCOUVER – Earlier this year, the US White House requested over $2.8 billion in funding from Congress for their “Cancer Moonshot” initiative, an ambitious plan to slash cancer rates in half within...

RY : 111.21 (+0.85%)
RY.TO : 151.58 (+0.81%)
ONCY : 1.0400 (+1.96%)
ONC.TO : 1.44 (+2.86%)
LLY : 948.40 (+1.53%)
IMGN : 31.23 (unch)
AZN : 79.24 (+1.67%)
MRK : 127.76 (-0.94%)

Barchart Exclusives

3 'Strong Buy' Semiconductor Picks for Penny Stock Speculators
Semiconductor penny stocks, such as Ideal Power, are high-risk, high-return investments that have the potential to deliver outsized gains to shareholders. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar